Why the study?
Does Sabin type 2 attenuated poliovirus vaccine prevent poliomyelitis in children during a type 1 epidemic?
Does Sabin type 2 attenuated poliovirus vaccine prevent poliomyelitis in children during a type 1 epidemic?
Report on the large-scale use of Sabin type 2 attenuated poliovirus vaccine during a type 1 poliomyelitis epidemic in Singapore in 1958.
Answers are grounded in this paper and cite their sources.
Historical 1958 report on type 2 vaccine use during type 1 epidemic should not change practice; leaves open cross-serotype protection.
In the latter half of 1958 Singapore experienced an epidemic outbreak of poliomyelitis due to the type I virus. Eleven weeks after the first case was reported the Minister of Health in the Singapore Government decided, after consultation, to make available the attenuated type 2 vaccine elaborated by Sabin (1957a, 1957b) for children between the ages of 3 months and 10 years. Dr. Sabin agreed to the release of this vaccine on condition that adequate laboratory control could be assured. The following communication gives the reasons for the selection of the type 2 vaccine, the experimental details, and the results of the campaign. TABLE I.-Incidence of Poliomyelitis in Singapore Since 1946 up to Period of Epidemic
No takes yet. Share an insight, caveat, or question.
Hale et al. (1959) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: